Patents by Inventor Renaud RESPAUD

Renaud RESPAUD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PULMONARY DELIVERY OF ANTIBODIES
    Publication number: 20230047809
    Abstract: The present invention relates to the pulmonary delivery of antibodies or antibody derivatives.
    Type: Application
    Filed: February 1, 2021
    Publication date: February 16, 2023
    Inventors: Sylvain HUILLE, Heloise AUDAT, Alexie MAYOR, Nathalie HEUZÉ-VOURC'H, Renaud RESPAUD
  • Antibody-drug conjugates and the use of same in therapy
    Patent number: 11278627
    Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: March 22, 2022
    Assignee: MC SAF
    Inventors: Nicolas Joubert, Marie Claude Viaud-Massuard, Renaud Respaud
  • NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY
    Publication number: 20190365914
    Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.
    Type: Application
    Filed: April 11, 2019
    Publication date: December 5, 2019
    Inventors: Nicolas JOUBERT, Marie Claude VIAUD-MASSUARD, Renaud RESPAUD
  • Antibody-drug conjugates and the use of same in therapy
    Patent number: 10307488
    Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: June 4, 2019
    Assignee: UNIVERSITE FRANCOIS RABELAIS
    Inventors: Nicolas Joubert, Marie Claude Viaud-Massuard, Renaud Respaud
  • NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY
    Publication number: 20160151515
    Abstract: Disclosed are novel antibody-drug conjugates and use thereof in therapy, in particular in anticancer or anti-inflammatory therapy, as well as synthetic products useful as linkers, composed of a linker head and a linker body, and also a method for preparing the linkers and the antibody-drug conjugates.
    Type: Application
    Filed: July 11, 2014
    Publication date: June 2, 2016
    Inventors: Nicolas JOUBERT, Marie Claude VIAUD-MASSUARD, Renaud RESPAUD